{
  "id": "61242f5abe65cfbf",
  "title": "FDA Accepts New Drug Application for Roche ? s Giredestrant in ESR1 - Mutated , Er - Positive Advanced Breast Cancer",
  "description": "20260220T081500Z",
  "content": "",
  "source": "marketscreener.com",
  "source_url": "https://www.marketscreener.com/news/fda-accepts-new-drug-application-for-roche-s-giredestrant-in-esr1-mutated-er-positive-advanced-brea-ce7e5ddddb8bf123",
  "published_at": "20260220T081500Z",
  "fetched_at": "2026-02-21T00:28:01.720640+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda",
    "drug"
  ],
  "location": "",
  "raw_data": {
    "url": "https://www.marketscreener.com/news/fda-accepts-new-drug-application-for-roche-s-giredestrant-in-esr1-mutated-er-positive-advanced-brea-ce7e5ddddb8bf123",
    "url_mobile": "",
    "title": "FDA Accepts New Drug Application for Roche ? s Giredestrant in ESR1 - Mutated , Er - Positive Advanced Breast Cancer",
    "seendate": "20260220T081500Z",
    "socialimage": "https://www.marketscreener.com/images/twitter_MS_fdnoir.png",
    "domain": "marketscreener.com",
    "language": "English",
    "sourcecountry": ""
  }
}